Overview of Protein Engineering

Proteins are the core carriers of life activities—enzymes that catalyze metabolism, antibodies that fight off pathogens, collagen that maintains body structure, and hormones that transmit signals are all essential pillars of life. The growth, metabolism, immunity, and reproduction of organisms all rely on the precise functioning of proteins.

Over millions of years of evolution, nature has produced various functionally stable natural proteins, but these naturally occurring molecules have certain limitations. Some proteins are unstable and easily lose activity, some have insufficient catalytic activity or low efficiency, and many have limited functional applications, making them hard to meet the diverse needs of modern industrial applications.

The emergence of protein engineering has broken the inherent constraints of natural evolution, allowing humans to actively modify, optimize, or even design entirely new protein molecules. It has gradually become a core biotechnology that empowers biomedicine, industrial manufacturing, and modern agriculture.

1. What is Protein Engineering

Protein engineering is an interdisciplinary field that combines molecular biology, biochemistry, computational science, and synthetic biology. Its core technological approaches fall into two categories: one relies on the central dogma of 'genes encoding proteins,' modifying, mutating, or reconstructing protein-coding genes to change their amino acid composition and 3D structure; the other directly modifies the expressed protein through chemical modification, immobilization, and other means, ultimately optimizing functional properties to obtain new artificial proteins that are more stable, more active, and more specific.

Compared to traditional biotechnology methods that extract or express natural proteins, protein engineering breaks the limitation of merely using natural products and gradually achieves the technological leap of custom-designing life molecules. It’s a highly promising direction for the development of modern bioengineering.

2. Technological Iteration in Protein Engineering

The development of protein engineering is a continuous process of innovation, with biotechnology steadily iterating and improving. The industry generally divides its development into three stages, from early targeted tweaks and emulating natural selection to today’s AI-powered intelligent design, continuously refining the technical system.

Technological Iterations of Protein Engineering

Era 1.0: Site-Directed Mutagenesis, Precision Tweaking of Protein Structures

Early protein engineering focused on site-directed mutagenesis technology. Researchers could fine-tune protein structures and optimize specific functions by changing the base sequence at specific gene sites and replacing local amino acid residues. This technique is straightforward and cost-effective in experiments but heavily relies on human understanding of the relationship between protein structure and function. Early modification work was mostly based on trial and error, with overall success rates being low and the modification effects somewhat limited.

Era 2.0: Directed Evolution, Simulating Efficient Natural Selection

The emergence of directed evolution technology addressed many shortcomings of site-directed mutagenesis. This technology doesn’t require pre-determining effective mutation sites. Instead, it creates massive gene mutation libraries through random mutations, combined with high-throughput screening, to identify high-performing mutants from a large pool of protein variants. After multiple rounds of iterative optimization, proteins with overall enhanced performance are obtained. Directed evolution doesn’t rely on complete prior knowledge of protein structures, has a relatively lower operational threshold, and covers a wider range of modifications. It can optimize structurally complex proteins whose mechanisms aren’t fully understood and has long been a mainstream technology for industrial enzymes and antibody optimization. However, the overall R&D cycle is still relatively long, and the trial-and-error cost is higher.

Era 3.0: AI-Enabled, Intelligent Design of New Proteins

Since the 21st century, the development of big data and artificial intelligence has driven protein engineering into a new stage of rational design and intelligent modification. Protein structure prediction models like AlphaFold have solved the mapping problem from sequence to structure. Coupled with AI toolchains, including protein language models, sequence design models, and function prediction models, our understanding of the relationship between protein sequences and structures has deepened.

Using computational simulations and bioinformatics analysis, researchers can accurately pinpoint gene mutation sites and even attempt to design completely novel proteins that don’t exist in nature. This effectively overcomes the blind trial-and-error limitation of traditional methods, making protein modification more precise, efficient, and customizable. Currently, the industry has established a system that integrates site-directed mutagenesis, directed evolution, and AI intelligent design, with different technologies suited to different R&D scenarios, providing diverse support for industrial application.

3. Diverse Applications: Empowering Multi-Industry Upgrades

With this continuously iterated technology system, the applications of protein engineering are expanding. It has matured in biomedicine, industrial manufacturing, and modern agriculture, continuously driving these industries toward higher efficiency, greener practices, and greater precision.

Application Scenarios of Protein Engineering

3.1. Biomedicine: Supporting Innovation in Precision Medicine

Biomedicine is the most mature field for the application of protein engineering. Many commonly used clinical drugs are essentially proteins, but natural therapeutic proteins often have issues like short half-life, poor stability, and the tendency to trigger immune rejection. Through artificial modifications, drug performance can be effectively optimized and clinical efficacy improved.

Natural insulin is metabolized quickly in the human body, requiring frequent injections for patients. Researchers have developed several strategies, such as changing the isoelectric point of insulin through site-directed mutations, chemically attaching long-acting fatty acid/PEG groups, and optimizing amino acid sequences to enhance stability. The resulting long-acting insulin can extend the half-life from a few hours to over 24 hours, effectively prolonging the drug’s action, reducing injection frequency, and significantly improving the medication experience for diabetes patients.

The iteration and upgrade of antibody drugs also rely on protein engineering. Traditional mouse-derived antibodies tend to cause immune rejection and side effects when used in humans. Through humanization of antibodies, the complementarity-determining regions (CDRs) of mouse antibodies are grafted onto human antibody frameworks, with a few back-mutations to maintain affinity, greatly reducing immunogenicity. Combined with fully human antibody preparation technologies, humanized and fully human antibodies have become mainstream drugs for treating cancer and autoimmune diseases. Additionally, modified thrombolytic enzymes, interferons, and cytokines show overall better stability and bioactivity and have become important supports in clinical treatment.

3.2. Industrial Manufacturing: Leading Green and Low-Carbon Development

In industrial biomanufacturing, protein engineering plays a key role in driving green industrial transformation. Industrial production generally requires enzymes that can withstand extreme conditions such as high temperature, acidity/alkalinity, and high osmotic pressure, whereas natural enzymes are stable only under mild physiological conditions, making them difficult to adapt to industrial needs. Through artificial modification, the heat tolerance and catalytic efficiency of industrial enzymes such as amylases, proteases, and lipases can be effectively improved.

Modified heat-resistant amylases can efficiently catalyze starch hydrolysis at high temperatures, widely used in food processing, papermaking, textiles, and other industries, helping to reduce energy consumption and improve operational efficiency. New eco-friendly proteases can replace some traditional chemical additives in laundering and leather processing, reducing the use of chemical reagents. Meanwhile, artificially designed new enzymes can catalyze chemical reactions that are difficult to achieve in nature, providing new routes for the biosynthesis of new materials and new energy, supporting the transformation of traditional chemical industry toward low-carbon biomanufacturing.

3.3. Modern Agriculture: Protecting Food and Ecological Security

In modern agriculture, protein engineering provides support for stable production, higher yields, and green agricultural development. Pests and diseases are major factors limiting crop yields. Traditional chemical pesticides can cause environmental pollution, pesticide residues, and pest resistance. Researchers have modified Bacillus thuringiensis insecticidal proteins to optimize their insecticidal activity and targeting. The improved insecticidal proteins act mainly on specific pests, are relatively safe for humans, livestock, and beneficial organisms, and offer significantly improved pest control efficiency.

Introducing modified insecticidal protein genes into crops allows for the cultivation of insect-resistant rice and corn, which can effectively fend off pests and reduce pesticide use, balancing crop yield increases with ecological protection. In addition, optimizing crop stress-resistant proteins can enhance drought, cold, and saline-alkaline tolerance, aiding in the development of barren lands. Modifying proteins related to fruit and vegetable preservation can slow down their aging and rotting, reduce storage and transportation losses, and support the multidimensional high-quality development of modern agriculture.

4. Existing Challenges: Technology and Systems Still Need Improvement

Although protein engineering has achieved phased technological breakthroughs and the scope of practical applications continues to expand, there are still many urgent problems in large-scale industrial use, with the issue of balancing protein performance being central.

The industry commonly faces the trade-off between protein activity, stability, and manufacturability. Increasing enzymatic activity usually requires a flexible active site, but boosting structural flexibility often reduces thermal stability; strengthening protein stability can make the structure too rigid, weakening catalytic activity. At the same time, manufacturability factors such as protein expression levels, solubility, and purification yield further constrain these performance optimizations. Mutants that perform well in the lab often cannot be scaled up easily for industrial use, and traditional trial-and-error approaches struggle to optimize all three core indicators simultaneously.

Additionally, the precise folding mechanisms of complex proteins are not fully understood, and predicting the functions of entirely new proteins still has room for improvement. High-throughput screening efficiency also needs to be further optimized. Meanwhile, biosafety and ecological safety assessment systems for artificially synthesized proteins need continuous improvement alongside technological development.

5. AI-Enabled Upgrade: Core Value of MatwingsVenus™ (Xiaowu™)

Faced with the performance trade-offs that traditional technologies struggle to solve, and with research cycles often taking one to two years in trial-and-error models, the deep integration of AI offers a new approach to breaking through bottlenecks in protein engineering. Unlike AlphaFold, which focuses on basic protein structure prediction, conversational protein R&D agents like MatwingsVenus™ (Xiaowu™), powered by proprietary protein large models, focus on practical engineering needs and push protein development from experience-based experimentation toward precision design.

MatwingsVenus™

To tackle the multiple balance issues of activity, stability, and manufacturability, MatwingsVenus™ (Xiaowu™) can comprehensively assess the multidimensional effects of hundreds of candidate mutations, screening for the optimal solutions across a massive mutation space while taking multiple core performance indicators into account. For example, in enzyme engineering, it can simultaneously optimize catalytic efficiency and thermal stability; in antibody modification, it balances affinity and alkaline resistance, effectively overcoming the performance trade-offs of traditional technologies.

During directed evolution, this AI agent can pre-screen and filter out low-efficiency or ineffective mutations through computational simulation, reducing a library of millions of experiments down to hundreds. Coupled with automated wet-lab platforms for multiple iterative cycles, it relies on a "design-validate-iterate" wet-dry closed loop to significantly shorten R&D timelines. In de novo design scenarios, it can create entirely new functional proteins that do not exist in nature based on actual functional requirements, breaking the performance limits of natural protein scaffolds.

In terms of practical impact, this AI-driven R&D approach shows remarkable advantages: it once completed the optimization of a non-alkali single-domain antibody into a ligand in 4 months, increasing its alkaline resistance fourfold, doubling its lifespan, and successfully scaling up to 5000-liter production, precisely solving multiple balancing issues of alkaline resistance, stability, and manufacturability for the protein. In antibody engineering and functional protein optimization, this system enables full-chain optimization of protein structure, performance, and production attributes, drastically shortening traditional lengthy R&D cycles, reducing experimental trial-and-error costs, and continually lowering the industrialization barrier for protein engineering.

Conclusion: Reshaping the Future of Life Molecule Technology

From modifying natural proteins to fill performance gaps to AI-powered design of entirely new life molecules, protein engineering has broken free from the slow pace of natural evolution, allowing humans to actively regulate and optimize protein functions. As a major breakthrough in basic life sciences research, it is also a key tool for empowering the transformation and upgrading of medicine, industry, and agriculture.

In the future, as AI technology and protein engineering continue to deeply integrate, related technical systems will keep improving and are expected to be applied in precision medicine, green manufacturing, ecological restoration, synthetic life, and more, continuously revolutionizing the biotechnology industry and providing ongoing technological support for human health and sustainable industrial development.